Joyson Karakunnel MD MS, FACP

Hematologic Oncology, Hospice & Palliative

Staff Hematologist-Oncologist

1635 N George Mason DrSuite 115Arlington, VA 22205
Phone+1 703-243-1310
Fax+1 703-243-0128

Dr. Karakunnel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Karakunnel's full profile Already have an account?

Education & Training

University of MarylandMS, Pharmacology, 2005 - 2008
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008
University of MarylandFellowship, Hematology and Medical Oncology, 2005 - 2006
Clinical Center at the National Institutes of HealthFellowship, Hospice and Palliative Medicine, 2005
Atlantic HealthResidency, Internal Medicine, 2000 - 2003

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 2005 - 2020
CA State Medical License 2017 - 2019
WI State Medical License 2012 - 2017
DC State Medical License 2015 - 2016
MD State Medical License 2003 - 2016
CT State Medical License 2012 - 2014
KY State Medical License 2013 - 2014
ME State Medical License 2012 - 2014
FL State Medical License 2008 - 2012
Join now to see all

Clinical Trials

A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer Start of enrollment: 2013 Oct 25
COMPLETED
PHASE1
A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies Start of enrollment: 2013 Dec 19
COMPLETED
PHASE1
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome Start of enrollment: 2014 May 20
COMPLETED
PHASE1

Publications & Presentations

PubMed

21 citations
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Julien Carvelli, Ferhat Meziani, Jean Dellamonica, Pierre-Yves Cordier, Jerome Allardet-Servent
Critical Care Medicine. 2022-12-01
250 citations
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Lacey J Padrón, Deena M Maurer, Mark H O'Hara, Eileen M O'Reilly, Robert A Wolff
Nature Medicine. 2022-06-01
40 citations
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translatio...
Claire F Friedman, Christine Spencer, Christopher R Cabanski, Katherine S Panageas, Daniel K Wells
Journal for Immunotherapy of Cancer. 2022-01-01

Press Mentions

Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis FungoidesJune 22nd, 2021
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business UpdateMay 3rd, 2021
Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial ResultsMarch 15th, 2021